Shatterproof Pre-Conference Workshop 

Robert Deforde and Gabby Granata

Separate Registration Required: Click Here to Register Now

 8:00 AM - 9:00 AM

 9:00 AM - 9:15 AM

 Welcome & Opening

 Keynote: Dr. Meaghan Thumath 

CONCURRENT SESSIONS 1-3
11:00 AM - 11:55 AM

11:00 AM - 11:55 AM

Moderator: 

 Concurrent Session 1

51. A better way: Living and Lived experience as critical advisors for improving innovation in post-overdose clinical care

• Leilani Reed, MA-P, CPC, SOR Care Navigator Trainer, Drug Use Health Advisor, Emergency Department Peer Trainer, Addictions, Drug & Alcohol Institute, University of Washington
• Mandy Sladky, MSN, RN, CARN, Clinical Project Manager, Addictions, Drug and Alcohol Institute, University of Washington
• Athena Pierce, AAC, LEAB Member and Clinical Support Specialist, The Union Hotel, Downtown Emergency Services Center (DESC)
• Teresa Winstead, Dual PhD Cultural anthropology and Policy Analysis, Indiana University, Bloomington, IN, Senior Research Scientist and Affiliate Associate Professor, Psychiatry and Behavioral Sciences Department / Addictions Drug and Alcohol Institute and Health Services and Population Health, University of Washington Medical School, and UW School of Public Health
• Caleb Banta-Green, PhD, MPH, MSW, Research Professor, Adjunct Research Professor, Health Systems and Population Health, Director for Center for Community-Engaged Drug Education. Epidemiology and Research Adjunct Research Professor, Epidemiology, Addiction, Drug & Alcohol Institute, Department of Psychiatry & Behavioral Sciences, Center for Community-Engaged Drug Education, Epidemiology and Research (CEDEER), UW School of Medicine, UW School of Public Health

Learner Objectives:

Objective 1: Describe partnering with organizations to recruit overdose survivors and people with lived and living experience of OUD for an advisory board to improve an overdose stabilization center.

Objective 2: Discuss Lived Expertise Advisory Board curriculum development for building community and comprehensive clinical feedback.

Objective 3: Share the Lived Expertise Advisory Board’s role in evaluating the overdose stabilization center's model of care.

Objective 4: Share resources for replicating lived experience involvement in OUD and overdose care improvement.

64. Mind the baby, Mind the parent. Results from a study to examine parenting among those who use substances

• Philip James, MSc in Nursing, MSc in Addiction Recovery, Registered Psychiatric Nurse, Assistant Professor in Mental Health Nursing, School of Nursing & Midwifery, Trinity College Dublin, Ireland
• Sonam Prakashini Banka-Cullen, PhD, Psychologist, Assistant Professor in Digital Health and Health InformaticsSchool of Nursing, Midwifery and Health Systems, University College Dublin, Ireland

 Concurrent Session 2

17. Testing a Tailored Digital Support Intervention for Pregnant Women in Addiction Recovery

• Phyllis Raynor, PhD, PMHNP-BC, CARN-AP, APRN, Associate Professor, College of Nursing, University of South Carolina

Learner Objectives:

Objective 1: Describe the purpose and potential benefit of leveraging digital technology to support recovery and parenting for pregnant women with Opioid Use Disorders.

Objective 2: Describe the benefits of using a community based participatory approach to tailor meaningful parenting and recovery supports for pregnant women with Opioid Use Disorders.

Objective 3: Discuss the results of the pilot randomized control trial which involved testing a tailored digital app versus a standard educational resource for pregnant women with opioid use disorders.

Objective 4: Appraise the value, benefits, and challenges of delivering a customized evidence-based digital support intervention to pregnant women with Opioid Use Disorders in natural ecosystems.

58. Exploring Barriers and Facilitators to Women’s Recovery Capital as it Relates to Sex Work and Sexual and Reproductive Autonomy

• Hartley Feld, RN, PhD, Associate Professor, Nursing, University of Kentucky - Lexington, KY
• Amanda Fallin-Bennett, RN, PhD, Associate Professor, Nursing, University of Kentucky - Lexington, KY
• Kacey Byczek,  BA, Harm Reductionist/research associate, Nursing, University of Kentucky - Lexington, KY
  
• Martha Tilson, PhD, Assistant Professor, Behavioral Science, University of Kentucky - Lexington, KY
  

Learner Objectives: 

Objective 1: Explore barriers and facilitators to recovery capital related to the intersection sexual and reproductive health, sex work and SUD.

Objective 2: Describe key findings from a mixed methods study and a peer support specialist training with actionable insights to inform recovery coaching.

Objective 3: Appraise benefits and risks to recovery as they relate to the continuum of sex work from choice and circumstance to coercion.

Objective 4: Highlight gaps in standard measurements of recovery capital as they relate to strengths and challenges for women.

 Concurrent Session 3

42. Advancing Equity in Medication Assisted Treatment for Black Men

• Janice Collins McNeil, PhD, APRN, PHN, CNS, FNP, BC, Associate Professor, Nursing, North Carolina Central University
• Christopher Edwards, PhD, Director, Kylyn Love/ Edwards’ NCCU Psychoneuroendocrine and Rare Diseases Laboratory & Adjunct Professor, Psychology, North Carolina Central University

Learners Objectives:

Objective 1: Contextualize structural and systemic drivers of inequitable MAT access for Black men, including historical, policy, and sociostructural factors contributing to disparities.

Objective 2: Describe epidemiologic trends and racial disparities in MAT utilization—particularly buprenorphine and methadone—among Black men.

Objective 3: Identify multilevel barriers (individual, provider, community, organizational, and policy-level) that limit access to and adherence with MAT for Black men.

Objective 4: Propose nursing-centered strategies to advance equitable MAT delivery, including practice innovations, education, community engagement, reentry linkage, and policy advocacy.

74. Barriers, Attitudes, and Beliefs of Black Men’s Engagement in Seeking Opioid Use Treatment

• Jolie S. Jemmott, MSN, RN, PMHNP-BC, PhD Student, School of Nursing, Duke University
  

Learners Objectives: 

Objective 1: Describe the historical patterns and key factors influencing opioid treatment-seeking behaviors among Black men.

Objective 2: Explain how behavioral beliefs, normative beliefs, and control beliefs shape opioid-seeking behaviors and treatment intentions among Black men.

Objective 3: Discuss the implications of these findings for developing culturally responsive interventions aimed at improving opioid treatment access and outcomes for Black men.

CONCURRENT SESSIONS 4-6
1:00 PM - 1:55 PM

1:00 PM - 1:55 PM 

Moderator

 Concurrent Session 4

7. Meeting the Substance Use Disorder Treatment Needs of Autistic People

• MaryAnne Murray, DNP, EdD, PMHNP-BC, FNP-BC, CARN-AP, SUDPT, Psychiatric/Mental Health Nurse Practitioner, Integrated Care, Balance Beams Wellness, PLLC, Ilwaco, Washington

Learner Objectives: 

Objective 1: List five behaviors which might suggest an individual has an Autism Spectrum Disorder.

Objective 2: Discuss the role of substance use in the lives of Autistic individuals.

Objective 3: Identify three ways that treatment programs could adapt to the special needs of Autistic clients to improve their treatment experiences.

Objective 4: List discharge planning and life planning objectives to help Autistic individuals achieve successful sobriety/abstinence and positive life satisfaction.

62. Understanding Autism Spectrum Condition and Substance Use Disorders: Rethinking Treatment Fit, Function, and Complexity in AUD, OUD and CUD

• Adrian Jugdoyal, RGN, RMN, NMP, TCH, FHEA, FIAAN, FRSA, FRSPH, Program Leader, College of Health, Medicine and Life Sciences, Brunel University London

Learner Objectives: 

Objective 1: To examine how Autism Spectrum Condition (ASC) influences the development, presentation, and functional use of substances in individuals with AUD, OUD, and CUD.

Objective 2: To examine how Autism Spectrum Condition (ASC) influences the development, presentation, and functional use of substances in individuals with AUD, OUD and CUD.

Objective 3: To evaluate the complexities and ethical considerations involved in supporting autistic adults whose substance use may serve adaptive or functional purposes, such as sensory regulation or anxiety reduction.

Objective 4: To evaluate the complexities and ethical considerations involved in supporting autistic adults whose substance use may serve adaptive or functional purposes, such as sensory regulation or anxiety reduction.

 Concurrent Session 5

34. Caring Within Constraints: Maternity Providers’ Moral Experiences Caring for Perinatal Women with Opioid Use Disorder Care

• Caroline Darlington, PhD, MSN, WHNP-BC, Post-doctoral Fellow, National Clinician Scholars Program, University of Pennsylvania
  
• Rebecca Clark, PhD, MSN, RN, CNM, WHNP-BC, FAAN, Assistant Professor, School of Nursing, University of Pennsylvania
  
• Connie M. Ulrich, PhD, RN, FAAN, Professor, School of Nursing, University of Pennsylvania
  
• Peggy Compton RN, PhD, FAAN, Professor Emeriti, School of Nursing, University of Pennsylvania
  

Learner Objectives: 

Objective 1: Describe the moral experiences of a national sample of maternity providers caring for perinatal women with opioid use disorder (OUD).

Objective 2: Identify key factors that support or hinder providers’ ability to deliver values-based, equitable care to women with OUD and their children.

Objective 3: Discuss implications for education, policy, and clinical practice to better support maternity providers and improve care outcomes for perinatal patients with OUD.

Objective 4: Recommend strategies to reduce challenges and strengthen provider capacity to deliver compassionate, nonjudgmental, and patient-centered care.

41. Enhancing Maternal and Neonatal Outcomes Through Perinatal Opioid Use Disorder Symposiums: Evidence from Provider Education Initiatives

• Keisha Nicole House, APRN-FPA, FNP-BC, Associate Professor of the Department of Psychiatry; Director of SUD-COE, Psychiatry, Rush University Medical Center, Chicago
• Paige Pickerl, MSW, LCSW, Community Research Manager, Department of Psychiatry, Rush University Medical Center, Chicago
• Tanya Sorrell, PhD, PMHNP-BC, FAANP, FAAN, Associate Professor of Psychiatry at Rush University Medical Center and Director of Rush’s Substance Use Disorder Center of Excellence, Department of Psychiatry, Rush University Medical Center, Chicago

Learner Objectives: 

Objective 1: Outline the impact of Opioid Use Disorder (OUD) in pregnancy and its implications for provider care.

Objective 2: Review how provider education initiatives influence screening, diagnosis, treatment and outcomes for pregnant individuals with OUD.

Objective 3: Summarize the evidence and implications for education initiatives for providers and the efficacy of building symposiums as tools for enhancing practice.

Objective 4: Discuss ongoing efforts to build symposiums to enhance perinatal care for individuals with OUD, and continued opportunities for intervention.

 Concurrent Session 6

19. Developing and Disseminating Open-Access Substance Use Education for Nurses (Advanced Practice nurses Opioid Use Disorder Massive Open Online Course (APROUD-MOOC) 

• Nicole Adams PhD, RN, Associate Research Professor, Regenstrief Center for Healthcare Engineering, Purdue University, West Lafayette

Learner Objectives: 

Objective 1: Build a team of content experts in SUD. We assembled a team of clinical and academic experts, including in educational technology, and an advisory board of treatment experts.

Objective 2: Create open-access modules to provide SUD education to nurse practitioner students. We created 8 modules that are open-access through canvas.

Objective 3: Apply new strategies in educational technology to improve the impact of the material across disciplines.

Objective 4: Disseminate to a broad audience. Using a multi-pronged approach we disseminated the materials to reach educators. We adapted the modules to become accredited continuing medical education for licensed professionals.

16. Beyond the Badge Harm Reduction: Law Enforcement Simulation in Opioid Overdose and Naloxone Administration

• Derrick C. Glymph, PhD, DNAP, CRNA, CHSE, CNE, FIAAN, FAANA, FAAN, Associate Professor, Nursing Anesthesia, Duke University School of Nursing
  
• Krystin Jones, BSN, RN, CCRN, MHA, SRNA, Nurse Anesthesia, Duke University School of Nursing
  

Learner Objectives: 

Objective 1: Identify signs and symptoms of opioid overdose and differentiate them from other causes of altered mental status or unresponsiveness

Objective 2: Demonstrate correct intranasal naloxone administration and appropriate post-reversal interventions using simulation-based practice scenarios.

Objective 3: Explain the role of law enforcement officers as first responders in opioid overdose emergencies and how rapid response impacts survival outcomes.

Objective 4: The opioid crisis continues to evolve with the rise of illicit fentanyl, posing significant challenges for first responders. In Durham County, North Carolina, law enforcement

CONCURRENT SESSIONS 7-9
2:00 PM - 2:55 PM

 Concurrent Session 7

55. Parents who inject drugs: Assessing the impact of a safe injecting facility on children and young people in a disadvantaged community 

• Catherine Comiskey, BA(Mod) MA, MSc, PhD, MA, FIMA, FTCD, Chair of Healthcare modelling, Global Addiction and Transformation, School of Nursing and Midwifery, Trinity College Dublin, The University of Dublin, Ireland
• Leo Jefferys, PG Dip (Post Graduate Diploma in Substance Use from Queen’s University Belfast), Peer Researcher, School of Nursing and Midwifery, Trinity College Dublin, The University of Dublin, Ireland
• Gillian Shorter, PhD, Reader in Clinical Psychology, Psychology Department, The Queen’s University Belfast, Ireland

Learner Objectives: 

Objective 1: To acknowledge the stigma parents from a local community face when using a safe injecting facility (SIF)

Objective 2: To include the voices of children and young people in an evaluation of a new local safe injecting facility

Objective 3: To evaluate the impact of a new pilot safe injecting facility on children and young people.

Objective 4: To provide recommendations on the extension of the pilot license for a new safe injecting facility from the perspective of the impact on children and young people in the community

65. Improving access and uptake of treatment services for substance using adolescents

• Philip James, MSc in Nursing, MSc in Addiction Recovery, Registered Psychiatric Nurse, Assistant Professor in Mental Health Nursing, School of Nursing & Midwifery, Trinity College Dublin, Ireland
• Michael Nash, Registered Psychiatric Nurse, PhD, Associate Professor in Mental Health Nursing, School of Nursing & Midwifery, Trinity College Dublin, Ireland
• Catherine Comiskey, BA(Mod) MA, MSc, PhD, MA, FIMA, FTCD, Chair of Healthcare modelling, Global Addiction and Transformation, School of Nursing and Midwifery, Trinity College Dublin, The University of Dublin, Ireland

Learner Objectives: 

Objective 1: To complete an international literature review examining barriers and enablers for the referral and access to treatment of young people who use substances.

Objective 2: Perform a retrospective quantitative analysis of existing treatment databases to objectively assess factors associated with attending and not attending substance use treatment among under 18s.

Objective 3: Examine the factors associated with attendance/non-attendance at substance use services in depth using a qualitative methodology.

Objective 4: To make recommendations for improving access and uptake to treatment for substance using adolescents, based on the three components of the study.

 Concurrent Session 8

37. Nurse-Led Group-Based Community Reinforcement and Family Training (CRAFT) in an Office-Based Opioid Treatment Program

• Addy Adwell, DNP, RN, CARN, AMB-BC, Assistance Nurse Manager, Office-Based Opioid Treatment, Harborview Medical Center, Seattle

Learner Objectives:

Objective 1:Explain Community Reinforcement and Family Training (CRAFT) and importance of engaging concerned significant others (CSOs)

Objective 2: Describe a nurse-led group-based CRAFT intervention for CSOs of people with opioid use disorder focused medication for opioid use disorder

Objective 3: Share results of a 10 session pilot CRAFT group and a staff survey regarding engaging CSOs

40. Patient advocacy and coordination of care for patients with substance use disorders: Clinical insights, opportunities, challenges, and best practices

• Mihaela Fletcher, DNP, PMHNP-BC, FNP-C, CARN-NP, CNE, FIAAN, Nurse Practitioner, Clinical Preceptor, Walter B. Jones Cetner, NC DHHS, Greenville
  
• Andrew Fletcher, MD, FAAFP, Retired Lieutenant Colonel, Family Medicine Physician, Staff Physician, Medical Director, US Army Medical Corps - Retired, Greenville

Learner Objectives: 

Objective 1: Recognize the signs and symptoms of opioid and stimulant intoxication, complications of chronic opioid and stimulant use, and significant interactions of methadone with other drugs.

Objective 2: Identify strategies for screening, clinical assessment, and monitoring guidelines for patients who do not disclose diagnoses and medication treatment for substance use disorders.

Objective 3: Explore the impact of ethical and legal challenges on patient safety and coordination of care for patients with substance use disorders.

Objective 4: Describe the roles of the addiction, primary care, and specialty care health care professionals in addressing barriers to the coordination of care for patients with substance use disorders.

 Concurrent Session 9

56. Reducing Opioid Overdose Deaths in Clallam County

• Kimberly Conley, MSN, PMHNP-BC, Psychiatric Mental Health Nurse Pratitioner, Mental Health, Olympic Peninsula Community Clinic, Port Angeles, Washington
• Virginia Conley, PhD, FNP-BC, PMHNP-BC, FAANP, Professor, retired, Nursing, University of Iowa, College of Nursing

Learner Objectives: 

Objective 1: To describe one under-resourced community’s approach to reducing opioid overdose deaths.

Objective 2: To illustrate the complex interplay required between agencies, professions, personalities, and communication systems for successful implementation of a harm reduction model that melds a variety of evidence-informed practices.

Objective 3: To present facilitators and barriers to successful model implementation.

Objective 4: To highlight the critical nurse practitioner role within the model.

68. Identifying Barriers to Helping Nursing with Substance Use Problems: Perspectives of Employee Assistance Professionals

• Victoria Selby, PhD, CRNP-PMH, PMHNP-BC, CARN-AP, Assistant Professor, School of Nursing, University of Maryland, Baltimore
• Soyeon Shim, MSN, RN, PhD Student, School of Nursing, University of Maryland, Baltimore
• Alison Trinkoff, RN ScD FAAN, Professor, School of Nursing, University of Maryland, Baltimore
• Jodi Frey, PhD, LCSW-C, CEAP, Professor, Associate Dean for Research, School of Social Work, University of Maryland, Baltimore
• Jung Min Yoon, PhD, MSN, RN, Assistant Professor, College of Nursing, Ehwa Womans University, Seoul, South Korea

Learner Objectives: 

Objective 1: Describe the multilevel barriers EAP professionals identify when assisting nurses with substance use problems.

Objective 2: Analyze how intrapersonal, interpersonal, organizational, and societal barriers interact to affect nurse help-seeking, treatment and recovery.

Objective 3: Identify evidence-informed strategies to strengthen workforce knowledge, organizational readiness, and early intervention pathways.

Objective 4: Apply the social ecological model to develop workforce and policy initiatives that promote equitable, recovery-supportive care for nurses.

Japan Panel: "The Current State of Addiction and Nursing in Japan"

• Keiichiro Kiriyama RN, PHN, CNS, Ph.D., Associate Professor, Department of Psychiatric and Mental Health Nursing, Graduate School of Nursing, Nagoya City University

• Asako Yoshino RN, PHN, CNS, Ph.D. Assistant Professor, Department of Global Health Nursing, Graduate School of Nursing, Nagoy City University

44. The Impact of Alcoholics Anonymous on the Recovery of Alcohol-Dependent Individuals in Japan Who Continue to Work

• Nozomi Fujisawa, Ph.D. in Nursing, RN, Lecturer, Nursing Course, School of Medicine, Yokohama City University, Yokohama, Japan
• Chihiro Yamamoto, Nursing Student, Nursing Course, School of Medicine, Yokohama City University, Yokohama, Japan
• Yuriko Tanabe, Ph.D., RN, Lecturer, Nursing Course, School of Medicine, Yokohama City University, Yokohama, Japan
• Keiichiro Kiriyama, Ph.D. in Nursing, RN, Associate Professor, School of Nursing, Nagoya City University, Nagoya, Japan
• Noriko Yamada, Ph.D. in Nursing, RN, Professor, Nursing Course, School of Medicine, Yokohama City University, Yokohama, Japan

Objective 1: Describe the specific challenges faced by alcohol-dependent individuals in Japan employed in a workplace where social norms and stigma persist.

Objective 2: Explain how participation in Alcoholics Anonymous (AA) influences recovery processes among employed individuals.

Objective 3: Compare the impact of AA in Japan with findings from international research to understand culturally specific factors.

Objective 4: Discuss how nurses can effectively collaborate with community-based recovery resources, including AA, to support employed individuals with alcohol dependence.

 FIAAN Meeting 

 8:00 AM -

9:00 AM

 9:00 AM -

9:55 AM

 Keynote: Michelle Byron

CONCURRENT SESSIONS 10-12
10:00 AM - 10:55 AM

10:00 AM -

10:55 AM

Moderator: 

 Concurrent Session 10

23. Using Nurse-Led MOUD Teams In the Hospital Setting for Early Recognition and Treatment of OUD 

• Sara Elisabeth Welty, DNP-APH, RN, CARN, Nurse Care Manager, Medications for Opioid Use Disorder, MultiCare Inland NW Hospitals, Spokane, Washington
  

Learner Objectives: 

Objective 1: Describe the role of nurse-led teams in initiating medications for opioid use disorder (MOUD) during hospitalization to improve access and patient outcomes.

Objective 2: Identify barriers to MOUD initiation in hospital settings and explain how nurse-led interventions can overcome these challenges.

Objective 3: Demonstrate understanding of standardized protocols and collaborative practice models supporting nurse-led MOUD initiation and continuity of care.

Objective 4: Evaluate the impact of nurse-led MOUD programs on patient engagement, hospital discharge outcomes, and linkage to community partners and resources.

49. ScalaNW: Expanding Access to MOUD in Acute Care Settings

• Maureen Oscadal, RN, MPH, BSN, CARN, AMB-BC, Clinical Programs & Implementation Specialist, Addictions, Drug & Alcohol Institute, University of Washington, Seattle
  
• Mandy Sladky, MSN, RN, CARN, Clinical Project Manager, Addictions, Drug & Alcohol Institute, University of Washington, Seattle
  
• Liz Wolkin, MSN, RN, CEN, NPD-BC, ScalaNW Program Manager, Clinical Quality and Care Transformation, Washington State Health Care Authority, Seattle
• LeiLani Reed, MA-P, CPC, Care Navigator Trainer, Drug Use Health Advisor, Emergency Department Peer Trainer, Addictions, Drug & Alcohol Institute, University of Washington, Seattle
  
• Kelly Youngberg, MHA, Assistant Director for Healthcare Implementation and Strategy, Addictions, Drug & Alcohol Institute, University of Washington, Seattle

Learner Objectives: 

Objective 1: Identify core components of a nurse-led, systems-level intervention that supports medication for opioid use disorder (MOUD) initiation in acute care settings.

Objective 2: Identify strategies for increasing clinician knowledge and competence in providing substance use disorder (SUD) care in acute care settings.

Objective 3: Describe the role of multidisciplinary teams in facilitating equitable access to MOUD.

Objective 4: Discuss the implementation of ScalaNW, a program that facilitates SUD treatment initiation in acute care settings and linkage to ongoing care.

10:00 AM -

10:55 AM

Moderator: 

Concurrent Session 11

31. Use of weekly injectable long acting buprenorphine to decrease discomfort and withdrawal symptoms while initiating buprenorphine in the outpatient setting

• Alex Fay, BSN, RN, CARN, Registered Nurse, Walk-in MAT Clinic, The Centers for Families and Children, Cleveland, Ohio

Learner Objectives: 

Objective 1: Appreciate the challenges that arise during typical transmucosal buprenorphine initiation in the fentanyl area including rates of precipitated withdrawal.

Objective 2: Identify three novel buprenorphine initiation methods that aim to minimize withdrawal symptoms

Objective 3: Summarize evidence for using "Direct to Inject" (DTI) buprenorphine to initiate buprenorphine.

Objective 4: Review a DTI algorithm used in an outpatient, low barrier MAT program in Cleveland Ohio.

39. Meeting Complexity With Consistency: Long-Acting Buprenorphine for High-Risk Populations

• Kayla Cross, ARNP, PMHNP-BC, ARNP, addictions / mental health, Bloom Psychiatry, Spokane, Washington

Learner Objectives: 

Objective 1: Describe the pharmacologic and clinical advantages of long-acting buprenorphine formulations in the treatment of opioid use disorder with complex populations.

Objective 2: Discuss practical considerations for implementing long-acting buprenorphine in diverse care settings, including patient selection, initiation strategies, follow-up, and integration with harm-reduction services.

Objective 3: Identify administration pearls for long-acting buprenorphine.

Objective 4: Evaluate real-world barriers and facilitators to adoption—such as stigma, access constraints, structural vulnerabilities, and workflow challenges—and propose strategies to optimize equitable treatment delivery.

10:00 AM -

10:55 AM

Moderator: 

 Concurrent Session 12

6. Building Confidence: Medical-Surgical Nurses and the Care of Patients with Opioid Use Disorders 

• Wendy Williams Gilbert, PhD, RN, CARN, NPD-BC, MEDSURG-BC, FIAAN, Medical Surgical System NPD, Center for Clinical Practice and Innovation, MultiCare Health System, Spokane, Washington
• Kari Scovack, MSN, RN, NPD-BC, MEDSURGBC, Medical Surgical System Educator, Center for Clinical Practice and Innovation, MultiCare, Auburn

Learner Objectives:

Objective 1: Identify the clinical challenges associated with caring for patients with OUD on the medical surgical units.

Objective 2: Describe evidence-based educational approaches utilized to redesign the nurse residency program with a strong focus on caring for patients with SUD.

Objective 3: Evaluate the changes in confidence and competency through the self-assessment tool developed for measuring SUD competency.

Objective 4: Discuss strategies to implement this work for existing nurses across the healthcare system.

30. Clinical Realities: Reflecting on What I Have Learned from Patients

• Archana Paul, RN, MScN, CCNE, CCSNE, FIAAN, Associate Professon, School of Nursing, Faculty of Health, York University, Toronto, Canada

Learner Objectives: 

Objective 1: To share lessons learned from patients in clinical practice for reflection and collective growth.

CONCURRENT SESSIONS 13-15
11:00 AM - 11:55 AM

11:00 AM -

11:55 AM

Moderator:  

Concurrent Session 13

8. Dissociative Substance Use Reported on StreetRx (2013–2024): Global Patterns and Clinical Considerations

43. Workplace Policies and Cross-System Collaboration to Support Nurses with Substance Use Disorders

• Alison Trinkoff, RN ScD FAAN, Professor, School of Nursing, University of Maryland, Baltimore
• Victoria Selby, PhD, CRNP-PMH, PMHNP-BC, CARN-AP, Assistant Professor, School of Nursing, University of Maryland, Baltimore 
• Soyeon Shim, MSN, RN, PhD Student, School of Nursing, University of Maryland, Baltimore
• Jodi Frey, PhD, LCSW-C, CEAP, Professor, Associate Dean for Research, School of Social Work, University of Maryland, Baltimore
• Jung Min Yoon, PhD, MSN, RN, Assistant Professor, College of Nursing, Ehwa Womans University, Seoul, South Korea

Learner Objectives: 

Objective 1: Describe how workplace policies, including zero-tolerance practices, influence nurses’ access to assessment, treatment, and recovery resources for substance use disorders.

Objective 2: Explain the communication and collaboration roles of Employee Assistance Program professionals (EAPs), Boards of Nursing (BONs), alternative-to-discipline programs (ATDs), employers, treatment providers, and recovering nurses in supporting equitable recovery pathways.

Objective 3: Identify key policy and reporting gaps that affect continuity of care and patient/public safety when nurses with substance use disorders (SUDs) move between employment settings.

Objective 4: Discuss evidence-informed strategies that healthcare organizations and leaders can use to promote early assessment, timely referral, and supportive re-entry for nurses in recovery.

11:00 AM -

11:55 AM

Moderator:  

Concurrent Session 14

46. Equipping the Nursing Workforce: NP and RN Roles in Administering Long-Acting Injectables for OUD 

• Jeffery Ramirez, PhD., PMHNP-BC, CARN-AP, FIAAN, FAANP, FAAN, Director of Graduate Programs and Professor, Nursing, Gonzaga University, Spokane, Washington
  
• Kayla Cross, MSN, MA, PMHNP, Psychiatric Nurse Practitioner, Nursing/Substance Abuse Treatment Program VA Medical Center and Owner of Bloom Psychiatry, Spokane, Washington
• Samantha Harris, RN, BSN, Case Manager in Substance Treatment Program/Registered Nurse, Nursing/Speciality Programs, VA Medical Center, Spokane, Washington

Learner Objectives: 

Objective 1: Describe the evidence base, indications, and clinical benefits of long-acting injectable medications for opioid use disorder and their role in improving treatment access and retention.

Objective 2: Differentiate Nurse Practitioner and Registered Nurse competencies related to assessment, administration, monitoring, and patient education when delivering LAI treatments for opioid use disorder.

Objective 3: Apply a competency-based framework to develop safe, patient-centered, and collaborative nursing practices that support equitable access to LAI treatment across diverse clinical settings.

Objective 4: Evaluate system-level, regulatory, and workflow considerations that influence the implementation of long-acting injectable medications for opioid use disorder and address barriers to equitable care delivery.

61. Long-Acting Injectable Buprenorphine—An Effective, Equitable, and Underutilized Approach to MOUD

• Sarah Cottingham, DNP, FNP-C, CNE, Clinical Associate, Community Health Improvement Partnership Program, Duke University School of Nursing, Durham

Learner Objectives: 

Objective 1: Describe the pharmacologic properties, therapeutic benefits, and clinical indications of long-acting injectable buprenorphine (LAI-B) within the spectrum of medications for opioid use disorder (MOUD).

Objective 2: Identify patient populations who may particularly benefit from LAI-B—such as individuals experiencing homelessness, justice-involved patients, and those with limited pharmacy access—and recognize common barriers that contribute to inequitable utilization.

Objective 3: Apply best practices for prescribing, administering, and monitoring LAI-B across diverse clinical settings, including community programs, correctional health, and low-barrier or harm-reduction–focused clinics.

Objective 4: Develop patient-centered strategies, including stigma-reduction and care-coordination approaches, to increase equitable access and improve continuity of care for individuals receiving LAI-B.

11:00 AM -

11:55 AM

Moderator:  

Concurrent Session 15

22. Global nurse prescribing for opioid use disorder: A scoping review

• Mary Ellen Biggerstaff, DNP, FNP, MPH, Associate Professor, School of Nursing, Pacific Lutheran University, Olympia
• Martha M. Whitfield, PhD, APRN, Assistant Professor, Community Nursing at the University of Massachusetts Dartmouth 
• Rosemary Wilson, PhD, RN(EC), Professor of Nursing, Queen’s University, Kingston, Canada

Learner Objectives: 

Objective 1: Describe the current state of global nurse prescribing for opioid use disorder (OUD), based on a review of the global literature.

Objective 2: Identify and categorize types and models of medication for OUD (MOUD) nurse prescribing at any level of nursing.

Objective 3: Discuss scope of practice and regulatory changes described in the literature on nurse prescribing of MOUD.

Objective 4: Discuss future global research and regularly changes

67. Nurse Prescribing of Opioid Agonist Treatment in Ireland: Evidence, Governance, and the Politics of Drug Policy Decision-Making

• Peter Kelly, PhD, Assistant Professor in Mental Health Nursing, School of Nursing and Midwifery, Trinity College Dublin, Ireland

Learner Objectives: 

Objective 1: To analyse how governance structures and professional hierarchies have shaped— and limited—consideration of nurse prescribing of OAT in Irish drug policy.

Objective 2: To examine how selective mobilisation of evidence has contributed to inequitable access to opioid agonist treatment

Objective 3: To highlight the policy, legislative, and workforce implications of excluding nursing expertise from national decision-making structures.

Objective 4: To propose equity-focused reforms that support inclusive, evidence-informed governance and expand access to OAT for marginalised populations.

 12:00 PM -

12:55 PM

 1:00 PM -

1:55 PM

 Keynote: Adam Searby

CONCURRENT SESSIONS 16-18
2:00 PM - 2:55 PM

 2:00 PM -

2:55 PM

Concurrent Session 16

11. A Morality Shift in Nursing: Reframing Ethics Through Humanity and Harm Reduction 

60. Addiction Nurses as Agents of Social Justice: Ethical Boundary-Work, Advocacy, and System Reform in Stigmatised Care Environments

• Adrian Jugdoyal, RGN, RMN, NMP, TCH, FHEA, FIAAN, FRSA, FRSPH, Program Leader, College of Health, Medicine and Life Sciences, Brunel University London, United Kingdom

Objective 1: Critically analyse the ethical principles that guide addiction nurses when advocating for patients, including circumstances where strict adherence to protocol may conflict with beneficence, justice, and harm-reduction principles.

Objective 2: Evaluate how stigma, organisational culture, and systemic inequities influence clinical decision-making and patient outcomes in addiction care settings

Objective 3: Assess real-world case scenarios to identify how addiction nurses navigate professional boundaries, challenge discriminatory practices, and implement evidence-informed strategies to support equitable treatment.

Objective 4: Develop an understanding of how nurse-led advocacy contributes to wider organisational and policy reform, promoting more compassionate, recovery-oriented, and socially just approaches to substance use disorders.

2:00 PM -

2:55 PM

Concurrent Session 17

26. Driving Change Through Compassionate Addiction Research and Education (CARE)

• Marissa Abram, PhD, PMHNP-BC, CARN-AP, FIAAN, Assistant Professor, Duke University School of Nursing (DUSON), Durham
• Alice Lazzar-Atwood, BSN Candidate, Undergraduate Student, Duke University School of Nursing (DUSON),Durham

Learner Objectives: 

Objective 1: Explore lived experiences of individuals who use substances and their interactions with healthcare providers.

Objective 2: Identify barriers to healthcare access, including stigma, discrimination, and service limitations.

Objective 3: Consider implications for community-engaged research and ethical participant engagement.

Objective 4:Use lived experience to develop learning competencies for harm-reduction education and training for pre-licensure healthcare students.

53. DEA Compliance: Ensuring compliance in an Narcotic Treatment Program setting

• Cynthia Hiscox, LPN, BS, Pharmacy Compliance Manager, Colonial Management Group, Maitland, Florida
  

Learner Objectives: 

Objective 1: Explain the key DEA regulations that govern Narcotic Treatment Programs (NTPs) and Opioid Treatment Programs (OTPs) and identify effective strategies to increase staff understanding and application of DEA NTP/OTP regulations

Objective 2: Recognize the key components to evaluate during internal audits.

Objective 3: Identify the types of documentation, reports, and operational data commonly requested during DEA audits, enabling teams to prepare materials proactively

Objective 4: Develop and implement internal quality-control reviews designed to strengthen compliance practices and ensure organizational readiness for DEA inspections

2:00 PM -

2:55 PM

Concurrent Session 18

9. From Data to Action: Culturally Responsive OD2A Strategies for Behavioral Health Providers 

• Ryan C. Warner, Ph.D., Consulting Psychologist, Executive Office, RC Warner Consulting, Katy
  

Learner Objectives: 

Objective 1: Describe the CDC’s Overdose Data to Action (OD2A) framework and its relevance to behavioral health practice.

Objective 2: Apply overdose data to design culturally responsive interventions that address disparities and improve client outcomes.

Objective 3: Integrate OD2A strategies across intrapersonal, interpersonal, and systemic levels of behavioral health practice.

Objective 4: Develop actionable plans to enhance organizational and community overdose prevention and recovery efforts.

15. No Bad Patients: Understanding substance use disorders from a trauma informed lens

• Lydia Bartholow, DNP, PMHNP, CARN-AP, FIANN, Medical Director, Substance Use Disorder Services, Oregon Health and Science University, Portland, OR
  

Learner Objectives: 

Objective 1: Understand the role of psychological trauma in the development of substance use disorders, with a focus on the neurobiology of both trauma and addiction

Objective 2: Identify the role of salience as it pertains to both traumatic experiences and substance use disorders

Objective 3: Name core principles of a trauma informed perspective in substance use disorder services

Objective 4: Recognize the role of structural violence (e.g. racism, poverty) within substance use disorders

 3:00 PM -

3:55 PM

North American Panel: "Global Perspectives on Addiction Nursing: Regional Realities, Workforce Challenges and Future Directions"

 4:00 PM -

4:55 PM

Zero Overdose Panel

5:00 PM -

5:30 PM 

 6:00 PM -

7:00 PM

 8:00 AM -

9:00 AM

 9:00 AM -

9:55 AM

 African Panel: "Global Perspectives on Addiction Nursing: Regional Realities, Workforce Challenges and Future Directions

 10:00 AM -

10:55 AM 

"Global Perspectives on Addiction Nursing: Regional Realities, Workforce Challenges and Future Direction"

 11:00 AM -

11:55 AM

 12:00 PM - 

12:55 PM

Keynote: John Furman